Refreshed 1 min ago
All7 days
Vertical
- All verticals
- Space
- Energy
- Quantum
- Robotics
- Cybersecurity
- Biotechnology
- Defense Tech
- Artificial Intelligence
× Show allIn focus
FDA seeks comment on early-phase solid tumor trial guidance
FDA published a draft guidance on Nov. 12 giving sponsors recommendations for early-phase IND protocols for solid tumor drugs and biologics. Public comments are open under docket FDA-2026-D-13432, with a deadline of Jan. 11 or 12, 2027 depending on the source. Finalization would follow the comment period, but no timeline appears in the items. · yesterday
Forces, money & more BiotechIn the News
0 articles in the past 7 days0No the news on this issue yet.
On the Hill
Congress, the White House and agencies5Ahead
Monday, Jan 11
11:59 PMAgencyFDAFDA's draft guidance on early-phase IND protocol recommendations for solid tumors is open for public comment through January 12, 2027 under docket FDA-2026-D-13432.Comment deadlineBiotechFDA seeks comment on early-phase solid tumor trial guidanceDetails7 linked
Tuesday, Jan 19
11:59 PMAgencyFDAFDA has opened a comment period on its draft guidance PSG_218436 covering remibrutinib, with comments due January 20, 2027.Comment deadlineBiotechDetails20 linked
Recent
Friday, Oct 25
Wednesday, Nov 11
Wednesday, Nov 18
4d agoCongressGAO concluded that FDA's IT strategic plan meets most leading planning practices but recommended FDA better document how it tracks modernization challenges, links its 17 major IT investments to strategic goals, and demonstrate use of performance metrics for one investment.Details29 linked
Nothing from this branch in view.
Times ET
Contracts
Solicitations, SBIR topics, grants and awards3GrantNational Institutes of HealthOct 20NIH seeks applications for consortium Translational Centers using Microphysiological Systems for Infectious Diseases (RFA-AI-28-012), with a $7M ceiling.$7M ceilingCloses in 68 daysRFA-AI-28-012BiotechLifecycle24 linked BAAFDA OFFICE OF ACQ GRANT SVCS6d agoFDA seeks proposals for advanced research and development of regulatory science under FDABAA-27-00123, responses due January 22, 2027.Closes in 61 daysFDABAA-27-00123BiotechLifecycle10 linked BAAFDA OFFICE OF ACQ GRANT SVCS5d agoFDA seeks proposals for advanced research and development of regulatory science under FY27 BAA FDABAA-27-00123, with responses due January 22, 2027.Closes in 61 daysFDABAA-27-00123BiotechLifecycle24 linked